Cold-adapted influenza viruses as a promising platform for viral-vector vaccines
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Expert review of vaccines - 15(2016), 10 vom: 07. Okt., Seite 1241-3 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Isakova-Sivak, Irina [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 26.02.2018 Date Revised 26.02.2018 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/14760584.2016.1208088 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM262129507 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM262129507 | ||
| 003 | DE-627 | ||
| 005 | 20231224201058.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/14760584.2016.1208088 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0873.xml |
| 035 | |a (DE-627)NLM262129507 | ||
| 035 | |a (NLM)27385419 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Isakova-Sivak, Irina |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cold-adapted influenza viruses as a promising platform for viral-vector vaccines |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 26.02.2018 | ||
| 500 | |a Date Revised 26.02.2018 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Influenza | |
| 650 | 4 | |a cold-adapted influenza virus | |
| 650 | 4 | |a live attenuated influenza vaccine | |
| 650 | 4 | |a recombinant vaccine | |
| 650 | 4 | |a virus vectors | |
| 650 | 7 | |a Antigens, Viral |2 NLM | |
| 650 | 7 | |a Influenza Vaccines |2 NLM | |
| 650 | 7 | |a Vaccines, Attenuated |2 NLM | |
| 650 | 7 | |a Vaccines, DNA |2 NLM | |
| 700 | 1 | |a Tretiak, Tatiana |e verfasserin |4 aut | |
| 700 | 1 | |a Rudenko, Larisa |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Expert review of vaccines |d 2002 |g 15(2016), 10 vom: 07. Okt., Seite 1241-3 |w (DE-627)NLM126545200 |x 1744-8395 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2016 |g number:10 |g day:07 |g month:10 |g pages:1241-3 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/14760584.2016.1208088 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2016 |e 10 |b 07 |c 10 |h 1241-3 | ||